Trial NCT01747499

View at ClinicalTrials.gov 
Org. Study IDs: 201303012
Secondary IDs: 1P50CA171963-01A1

Last trial update was posted on 2019-10-16

MeSH Interventions

Azacitidine

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions


Stopping Reasons

Enrolling 8 more patients would be statistically unlikely that the primary endpoint would be reached (reduce day 180 grade II-IV GVHD rates to 20% or less)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID